Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $330.11 | 24 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $128.41 | 11 | $0 (2018) |
| Lundbeck LLC | $48.31 | 3 | $0 (2017) |
| Otsuka America Pharmaceutical, Inc. | $43.70 | 3 | $0 (2018) |
| Neurocrine Biosciences, Inc. | $31.99 | 2 | $0 (2018) |
| Takeda Pharmaceuticals U.S.A., Inc. | $31.81 | 2 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $29.19 | 2 | $0 (2018) |
| Neuronetics, Inc. | $16.70 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2018 | $177.45 | 14 | Sunovion Pharmaceuticals Inc. ($70.27) |
| 2017 | $152.66 | 10 | Sunovion Pharmaceuticals Inc. ($58.14) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/16/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $10.39 | General |
| Category: CNS | ||||||
| 10/26/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: Central Nervous System (CNS) | ||||||
| 10/19/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: CNS | ||||||
| 09/21/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: CNS | ||||||
| 09/19/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $5.01 | General |
| Category: CNS | ||||||
| 09/14/2018 | Janssen Pharmaceuticals, Inc | INVEGA TRINZA (Drug), INVEGA SUSTENNA | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Neuroscience | ||||||
| 09/07/2018 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: PSYCHIATRY | ||||||
| 08/17/2018 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: NEUROLOGY | ||||||
| 07/20/2018 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: Neuroscience | ||||||
| 05/11/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: CNS | ||||||
| 05/11/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $1.36 | General |
| Category: CNS | ||||||
| 05/02/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $3.64 | General |
| Category: CNS | ||||||
| 02/28/2018 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: NEUROLOGY | ||||||
| 01/26/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $12.82 | General |
| Category: Central Nervous System (CNS) | ||||||
| 11/09/2017 | Neuronetics, Inc. | NeuroStar TMS Therapy (Device) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: NeuroStar TMS Therapy | ||||||
| 11/03/2017 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: PSYCHIATRY | ||||||
| 06/20/2017 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $8.34 | General |
| Category: CNS | ||||||
| 04/25/2017 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: CNS | ||||||
| 03/24/2017 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: CNS | ||||||
| 03/22/2017 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: PSYCHIATRY | ||||||
| 03/17/2017 | Lundbeck LLC | ABILIFY MAINTENA (Drug) | Food and Beverage | Cash or cash equivalent | $21.32 | General |
| Category: PSYCHIATRY | ||||||
| 03/02/2017 | Lundbeck LLC | TRINTELLIX (Drug) | Food and Beverage | Cash or cash equivalent | $10.59 | General |
| Category: PSYCHIATRY | ||||||
| 02/15/2017 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: CNS | ||||||
| 01/13/2017 | Lundbeck LLC | ABILIFY MAINTENA (Drug) | Food and Beverage | Cash or cash equivalent | $16.40 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 78 | 147 | $22,168 | $10,038 |
| 2022 | 6 | 171 | 334 | $40,253 | $17,028 |
| 2021 | 6 | 216 | 600 | $79,048 | $31,272 |
| 2020 | 7 | 168 | 283 | $43,148 | $16,441 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 31 | 96 | $11,424 | $5,538 | 48.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 32 | 34 | $7,718 | $3,092 | 40.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 15 | 17 | $3,026 | $1,407 | 46.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 42 | 93 | $11,082 | $5,038 | 45.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 29 | 51 | $8,109 | $3,558 | 43.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 37 | 65 | $7,735 | $2,599 | 33.6% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 32 | 94 | $6,280 | $2,571 | 40.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 17 | 17 | $3,859 | $1,735 | 45.0% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 14 | 14 | $3,188 | $1,527 | 47.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 36 | 80 | $12,720 | $6,538 | 51.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 46 | 101 | $12,019 | $5,423 | 45.1% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 18 | 133 | $13,167 | $3,899 | 29.6% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Office | 2021 | 17 | 114 | $11,286 | $3,316 | 29.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 19 | 49 | $6,461 | $2,719 | 42.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Office | 2021 | 15 | 46 | $6,164 | $2,465 | 40.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Office | 2021 | 17 | 22 | $5,544 | $2,150 | 38.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Office | 2021 | 19 | 23 | $4,577 | $1,822 | 39.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 12 | 14 | $3,528 | $1,470 | 41.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 17 | 18 | $3,582 | $1,468 | 41.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 35 | 70 | $11,130 | $4,894 | 44.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 40 | 85 | $10,115 | $2,544 | 25.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 19 | 19 | $4,598 | $2,131 | 46.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Office | 2020 | 23 | 25 | $4,975 | $2,058 | 41.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Office | 2020 | 18 | 36 | $4,824 | $2,009 | 41.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Office | 2020 | 17 | 18 | $4,536 | $1,898 | 41.8% |
About Dr. Vinodkumar Paddolkar, M.D
Dr. Vinodkumar Paddolkar, M.D is a Psychiatry healthcare provider based in Springfield, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/05/2009. The National Provider Identifier (NPI) number assigned to this provider is 1619108842.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vinodkumar Paddolkar, M.D has received a total of $330.11 in payments from pharmaceutical and medical device companies, with $177.45 received in 2018. These payments were reported across 24 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($330.11).
As a Medicare-enrolled provider, Paddolkar has provided services to 633 Medicare beneficiaries, totaling 1,364 services with total Medicare billing of $74,778. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Other Specialties Psychiatry
- Location Springfield, MO
- Active Since 08/05/2009
- Last Updated 12/22/2025
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1619108842
Products in Payments
- LATUDA (Drug) $128.41
- ABILIFY MAINTENA (Drug) $65.07
- INGREZZA (Drug) $31.99
- Trintellix (Drug) $31.81
- NeuroStar TMS Therapy (Device) $16.70
- REXULTI (Drug) $16.35
- INVEGA TRINZA (Drug) $15.01
- INVEGA SUSTENNA (Drug) $14.18
- TRINTELLIX (Drug) $10.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Springfield
Dr. Kalpana Vishnupad, M.d, M.D
Psychiatry — Payments: $63,945
Dr. Andrea Stonecipher, M.d, M.D
Psychiatry — Payments: $28,609
Dr. Shirlann Knight, M.d, M.D
Psychiatry — Payments: $9,255
Dr. Umamaheswara Vellanki, M.d, M.D
Psychiatry — Payments: $9,082
Dr. Dennis Dobard, M.d, M.D
Psychiatry — Payments: $8,804
Dr. Obiora Onwuameze, Md, Ms, Phd, MD, MS, PHD
Psychiatry — Payments: $6,358